# COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2

> **NIH NIH N01** · UNIVERSITY OF GEORGIA · 2022 · $61,062

## Abstract

The Georgia University Research Foundation to support the National Cancer Institute's multi-site study seeking to evaluate antibody responses to SARS-CoV-2 virus in high risk  populations including health workers, first responders, frontline worker (e.g. grocery store employees) and disproportionately affected minorities.  The goal of the study is to determine the durability of antibody titers following COVID infection and to identify correlates of antibody-mediated protection from re-infection in COVID survivors.

## Key facts

- **NIH application ID:** 10621133
- **Project number:** 75N93019C00052-P00014-9999-3
- **Recipient organization:** UNIVERSITY OF GEORGIA
- **Principal Investigator:** TED ROSS
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $61,062
- **Award type:** —
- **Project period:** 2019-09-10 → 2023-05-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10621133

## Citation

> US National Institutes of Health, RePORTER application 10621133, COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2 (75N93019C00052-P00014-9999-3). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10621133. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*